Previous 10 | Next 10 |
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, April 30, 2019. Management will hold a conference call to review the company's financ...
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received FDA 510(k) market clearance from the U.S. Food and Drug Administration (FDA) fo...
The following slide deck was published by GenMark Diagnostics, Inc. in conjunction with this Read more ...
GenMark Diagnostics, Inc. (GNMK) Q4 2018 Earnings Conference Call February 21, 2019, 04:30 PM ET Company Participants Leigh Salvo - IR Hany Massarany - President and CEO Scott Mendel - CFO Johnny Ek - Corporate Controller Conference Call Participants Brian Weinstein - Wil...
GenMark Diagnostics (NASDAQ: GNMK ): Q4 GAAP EPS of -$0.21 misses by $0.04 . More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ended December 31, 2018. Financial Highlights ...
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the expansion of its executive leadership team. Effective immediately, Scott Mendel, currently GenMar...
CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences. GenMark’s manag...
The Portfolio Barometer This article continues the weekly update on market conditions based on the types of portfolios that are outperforming or absent from the list of top-performing stocks. Portfolio strategies may experience the same autocorrelation that sustains strong price movements am...
CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close on Thursday, February 21, 2019. Management will hold a conference call to review the Company's fi...
News, Short Squeeze, Breakout and More Instantly...
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New ...
Healthcare giant Roche Holding (OTC: RHHBY) recently announced plans to acquire GenMark Diagnostics (NASDAQ: GNMK) in a deal valued at around $1.8 billion. The news sent GenMark's shares soaring close to 30%. In this Motley Fool Live video, recorded on March 17 , Mot...
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...